A detailed history of Federated Hermes, Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 799,978 shares of RAPT stock, worth $887,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
799,978
Previous 796,080 0.49%
Holding current value
$887,975
Previous $2.43 Million 33.81%
% of portfolio
0.0%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.76 - $3.75 $6,860 - $14,617
3,898 Added 0.49%
799,978 $1.61 Million
Q2 2024

Aug 08, 2024

BUY
$2.89 - $9.38 $1.5 Million - $4.88 Million
520,368 Added 188.74%
796,080 $2.43 Million
Q1 2024

May 14, 2024

BUY
$6.87 - $26.45 $1.89 Million - $7.29 Million
275,712 New
275,712 $2.48 Million
Q1 2023

May 08, 2023

BUY
$17.19 - $30.8 $300,979 - $539,277
17,509 New
17,509 $321,000
Q4 2021

Feb 14, 2022

SELL
$29.5 - $39.5 $1,829 - $2,449
-62 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$29.86 - $39.47 $1,851 - $2,447
62 New
62 $2,000
Q2 2020

Aug 13, 2020

SELL
$14.16 - $32.85 $9,288 - $21,549
-656 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$11.86 - $48.86 $7,780 - $32,052
656 New
656 $14,000

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $32.9M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.